Quote:
Originally Posted by Replaced_Texan
There is a study. What I find much more interesting is the ongoing research with the BCG vaccine, which may explain why there haven't been the type of outbreaks in places like Africa and Central America as there has been in more developed countries. 100 million babies a year get it all over the world.
Every scientist in the world who has the ability is looking into all of these possible solutions. Pinning hopes on one or another is probably not going to work, but in combination they might buy time to get to the vaccine.
BTW, my favorite part of the BCG wiki is yet another demonstration that the US method of relying on capitalism through monopoly has some very fucked up results. |
Can someone please put that in Trump’s hand before his next presser? It sounds like it has at least as much promise as hydrochloroquine. We should try it ASAP, everywhere.
I’d really like to see convalescent serum become a treatment as it’s a pretty easily and well understood therapy, but I understand it has a long pipeline to mass public dosage.
As to US price, a silver lining in this tragic mess is we’re going to wind up with single payer sooner than later. This is kind of a Waterloo for private insurance.
ETA: The study of 1000 patients from France had flaws in comparison to longer term studies. But how couldn’t it? It’s comparing battlefield triage with ER-on-a-years-worth-of-suburban-ER-visits treatment.
The same logical reason to try this TB drug underpins the argument in favor of the malaria drug.
